Clinical diagnostics encompasses the detection, diagnosis, and monitoring of diseases and health conditions in patients. Utilizing advanced lab techniques and medical technologies, clinical scientists and healthcare professionals analyze samples such as blood, urine, and tissue to identify biomarkers, pathogens, and other indicators of illness. From point of care testing (POCT) to precision medicine approaches, clinical diagnostics plays a crucial role in early intervention, treatment planning, and disease management. Explore how this field empowers clinicians to deliver accurate diagnoses and improve patient outcomes.
The Xpert PML-RARA Linearity Panel C221 is intended for use as a reference material to monitor the reportable range of in vitro laboratory nucleic acid testing procedures for the quantitative detection of PML-RARA transcript isoform bcr1 and ABL1 endogenous control mRNA transcript when analyzed using the Xpert® PML-RARA assay on Cepheid GeneXpert® Instrument Systems.
Xpert Bladder Cancer Panel C104 is intended for use as a quality control to monitor the performance of in vitro laboratory nucleic acid procedures for the qualitative detection of five RNA transcripts, CRH, IGF2, UPK1B, ANXA10, ABL1, performed on Cepheid GeneXpert® Systems with assays Xpert® Bladder Cancer Monitor and Xpert® Bladder Cancer Detection.
The SPOTFIRE® RSP Pos & Neg Controls kit is intended for use (as applicable) as an external positive and negative assayed quality control to monitor performance of in vitro laboratory nucleic acid testing procedures for the qualitative detection of pathogens.
The BioFire® JI Control Panel M420 is intended for use as an external positive and negative assayed quality control to monitor the performance of in vitro laboratory nucleic acid testing procedures for the qualitative detection of gram-positive and gram-negative bacteria, antimicrobial resistance gene, and yeast pathogens included in the BioFire® Joint Infection (JI) Panel on the BioFire® systems.
FilmArray® Pneumonia/Pneumoniaplus Control is intended for use as an external positive and negative assayed quality control to monitor the performance of in vitro laboratory nucleic acid testing procedures for the qualitative detection of bacteria, antimicrobial resistance genes, and viruses included in the FilmArray® Pneumonia Panel or Pneumonia Panel plus assay performed on the FilmArray® systems.
ACE UltraCore SuperC18 and SuperPhenylHexyl phases are manufactured using our unique Encapsulated Bonding Technology (EBT). This technology dramatically increases ligand coverage of the silica surface and effectively eliminates the negative effects of unbonded silanol groups. The higher ligand coverage results in improved inertness, chromatographic performance and stability.
The FilmArray® BCID2 Control Panel M416 is intended for use as an external positive and negative assayed quality control to monitor the performance of in vitro laboratory nucleic acid testing procedures for the qualitative detection of antimicrobial resistance genes, Gram positive and Gram negative bacteria, and yeast pathogens included in the BioFire® Blood Culture Identification 2 Panel on the BioFire® FilmArray® systems.
Xpert BCR-ABL1 p190 Control Panel C183 is intended for use as reference material to monitor the performance of the in vitro quantitative detection of p190 BCR-ABL1 translocation mRNA transcript and the ABL1 endogenous control mRNA transcript.
Xpert FII & FV NOR/MUT Control is intended for in vitro use as a quality control to monitor analytical performance of FII & FV detection on the GeneXpert® System. Xpert FII & FV NOR/MUT Control is formulated to monitor the detection of mutations Factor II G20210A and Factor V Leiden G1691A, the most common genetic risk factors for thrombotic events.
Xpert BCR-ABL IS Panel C130 is intended for in vitro diagnostic use as assayed external quality controls to monitor the performance of the in vitro quantitative detection of BCR-ABL1 translocation mRNA e14a2/b3a2 transcripts and the ABL1 endogenous control mRNA transcript.
